A United Kingdom supplier, with 30 awarded contracts, totalling £525.5m, most recently 3 months ago.
This procurement opportunity involves the acquisition of antiviral medications as part of the National Treatment and Monitoring Program for individuals with HIV/AIDS and post-exposure treatment. The procurement is divided into 20 lots. Interested suppliers must request clarifications or additional i
This procurement procedure involves the acquisition of various medicines and antineoplastics, divided into 301 lots as specified in the public procurement documentation. Contracts will be awarded quarterly, and the quantities listed are estimates. The contracting authority is not obligated to purcha
This contract involves the supply of a range of medicines to the Clinical Hospital of Psychiatry and Neurology in Brașov, Romania. The total value of the contract is approximately €477,575.33. Suppliers are invited to provide diverse pharmaceutical products that meet the health sector's requirements
This procurement opportunity involves the supply of essential pharmaceutical products necessary for patient treatment. The absence of these products poses a significant risk to patient health. The contract will cover the purchase of medications in specified forms and quantities as outlined in the te
The contracting authority intends to purchase a variety of oncology medicines to ensure the proper functioning of hospital activities. The procurement will include specific quantities and technical specifications as outlined in the terms of reference. There are minimum and maximum quantities for the
This contract involves the procurement of various medications across all categories, divided into 28 lots. Each medication purchased represents a separate lot. Detailed information regarding quantities and values can be found in the attached Excel file. Suppliers have 18 days to request clarificatio
This framework agreement is for the supply of medications in the category of antineoplastic and immunomodulatory drugs, covering 7 lots including aflibercept, methotrexate, topotecan, fluorouracil, mesna, and dacarbazine. Detailed specifications can be found in the tender documentation and the lots
This contract involves the supply of antihemorrhagic medicines and vaccines, divided into two lots as detailed in the specifications document. The contracting authority will respond to all clarification requests on the 13th day before the deadline for submitting offers. Suppliers have 20 days to req
This procurement opportunity involves the acquisition of various medicines, divided into 157 lots, as outlined in the public procurement procedure. Suppliers are invited to submit their offers for these lots, adhering to the specifications detailed in the Terms of Reference. Suppliers have 18 days t
This contract involves the procurement of various medicines as outlined in Section II.2 - List of Lots in this announcement and the Specifications Document - Annex 1 Quantities - various medicines. Suppliers have until 20 days before the bid submission deadline to request clarifications or additiona
